Associations of mitochondrial polymorphisms with sporadic colorectal adenoma
Corresponding Author
Bharat Thyagarajan
Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, Minnesota
Correspondence
Bharat Thyagarajan, Department of Laboratory Medicine and Pathology, University of Minnesota, 515, Delaware Street SE, Room 1-136 Moos Tower, Minneapolis, MN 55455.
Email: [email protected]
Search for more papers by this authorWeihua Guan
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota
Search for more papers by this authorVeronika Fedirko
Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia
Search for more papers by this authorHelene Barcelo
Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, Minnesota
Search for more papers by this authorRamya Ramasubramaian
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota
Search for more papers by this authorMyron Gross
Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, Minnesota
Search for more papers by this authorMichael Goodman
Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia
Search for more papers by this authorRoberd M. Bostick
Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia
Search for more papers by this authorCorresponding Author
Bharat Thyagarajan
Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, Minnesota
Correspondence
Bharat Thyagarajan, Department of Laboratory Medicine and Pathology, University of Minnesota, 515, Delaware Street SE, Room 1-136 Moos Tower, Minneapolis, MN 55455.
Email: [email protected]
Search for more papers by this authorWeihua Guan
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota
Search for more papers by this authorVeronika Fedirko
Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia
Search for more papers by this authorHelene Barcelo
Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, Minnesota
Search for more papers by this authorRamya Ramasubramaian
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota
Search for more papers by this authorMyron Gross
Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, Minnesota
Search for more papers by this authorMichael Goodman
Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia
Search for more papers by this authorRoberd M. Bostick
Department of Epidemiology, Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, Georgia
Search for more papers by this authorAbstract
Somatic mutations in mitochondrial DNA have been reported in colorectal adenomatous polyps (adenomas), the precursors to most colorectal cancers. However, there are no reports of associations of germline variation in mitochondrial DNA with adenoma risk. We investigated associations of germline polymorphisms in the displacement loop (D-loop) and non-D-loop region of the mitochondrial genome with incident, sporadic colorectal adenoma in three pooled colonoscopy-based case-control studies (n = 327 adenoma cases, 420 controls) that used identical methods for case and risk factor ascertainment. We sequenced a 1124 bp fragment to identify all genetic variation in the mitochondrial D-loop region, and used the Sequenom platform to genotype 64 tagSNPs in the non-D-loop region. We used multivariable unconditional logistic regression to estimate associations of the polymorphisms with adenoma. The odds ratios (OR) for associations of four polymorphisms in the HV1 region (mt16294, mt16296, mt16278, mt16069) with adenoma were 2.30, 2.63, 3.34, and 0.56, respectively; all 95% confidence intervals (CI) excluded 1.0, however, after correction for multiple comparisons, none of the findings remained statistically significant. Similar results were found for six polymorphisms in the non-D-loop region. In the HV1 region poly C tract, relative to those with 5 repeats, the ORs for those with fewer or more repeats were, respectively, 2.29 (95%CI 1.07-4.89) and 0.63 (95%CI 0.36-1.08), but repeat numbers in the HV2 region were not associated with adenoma. These findings suggest that mitochondrial D-loop HV1 region polymorphisms may be associated with colorectal adenoma risk and support further investigation.
REFERENCES
- 1 Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011; 20: 576–590.
- 2 Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009; 417: 1–13.
- 3 Crespo-Sanjuan J, Calvo-Nieves MD, Aguirre-Gervas B, et al. Early detection of high oxidative activity in patients with adenomatous intestinal polyps and colorectal adenocarcinoma: myeloperoxidase and oxidized low-density lipoprotein in serum as new markers of oxidative stress in colorectal cancer. Lab Med. 2015; 46: 123–135.
- 4 Kong SY, Bostick RM, Flanders WD, et al. Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation. Cancer Epidemiol Biomarkers Prev. 2014; 23: 545–554.
- 5 Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981; 290: 457–465.
- 6 Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res. 2001; 488: 119–133.
- 7 Clayton DA. Transcription and replication of mitochondrial DNA. Hum Reprod. 2000; 15: 11–17.
- 8 Croteau DL, Bohr VA. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem. 1997; 272: 25409–25412.
- 9 Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science. 1999; 286: 774–779.
- 10 Liou CW, Lin TK, Chen JB, et al. Association between a common mitochondrial DNA D-loop polycytosine variant and alteration of mitochondrial copy number in human peripheral blood cells. J Med Genet. 2010; 47: 723–728.
- 11 Lievre A, Chapusot C, Bouvier AM, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol. 2005; 23: 3517–3525.
- 12 Errichiello E, Venesio T. Mitochondrial DNA variants in colorectal carcinogenesis: drivers or passengers? J Cancer Res Clin Oncol. 2017; 143: 1905–1914.
- 13 Chang SC, Lin PC, Yang SH, Wang HS, Liang WY, Lin JK. Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis. 2009; 24: 623–628.
- 14 Govatati S, Saradamma B, Malempati S, et al. Association of mitochondrial displacement loop polymorphisms with risk of colorectal cancer in south Indian population. Mitochondrial DNA A DNA Mapp Seq Anal. 2017; 28: 632–637.
- 15 Tipirisetti NR, Govatati S, Pullari P, et al. Mitochondrial control region alterations and breast cancer risk: a study in South Indian population. PLoS ONE. 2014; 9: e85363.
- 16 Yacoubi Loueslati B, Troudi W, Cherni L, Rhomdhane KB, Mota-Vieira L. Germline HVR-II mitochondrial polymorphisms associated with breast cancer in Tunisian women. Genet Mol Res GMR. 2010; 9: 1690–1700.
- 17 Kong D, Shi S, Li Y, Li R, Li M. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of epithelial ovarian cancer. Mitochondrial DNA A DNA Mapp Seq Anal. 2016; 27: 1141–1143.
- 18 Liu S, Shi S, Li Y, Kong D. Identification of sequence nucleotide polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for epithelial ovarian cancer. Mitochondrial DNA A DNA Mapp Seq Anal. 2016; 27: 9–11.
- 19 Ebner S, Lang R, Mueller EE, et al. Mitochondrial haplogroups, control region polymorphisms and malignant melanoma: a study in middle European Caucasians. PLoS ONE. 2011; 6: e27192.
- 20 Wang C, Zhang F, Fan H, et al. Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome. Biochem Biophys Res Commun. 2011; 406: 493–496.
- 21 Kong D, Shi S, Li Y. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA are associated with epithelial ovarian cancer prognosis. Mitochondrial DNA. 2015; 26: 848–850.
- 22 Fang H, Shen L, Chen T, et al. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer. 2010; 10: 421.
- 23 Iwao N, Iwao S, Kobayashi F, et al. No association of the mitochondrial genotype (Mt5178A/C) with six cancers in a Japanese population. Asian Pac J Cancer Prev. 2003; 4: 331–336.
- 24 Webb E, Broderick P, Chandler I, et al. Comprehensive analysis of common mitochondrial DNA variants and colorectal cancer risk. Br J Cancer. 2008; 99: 2088–2093.
- 25 Potter JD, Bigler J, Fosdick L, et al. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms. Cancer Epidemiol Biomarkers Prev. 1999; 8: 69–75.
- 26 Lewis RC, Bostick RM, Xie D, et al. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res. 2003; 63: 8549–8553.
- 27 Daniel CR, Bostick RM, Flanders WD, et al. TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma. Cancer Epidemiol Biomarkers Prev. 2009; 18: 65–73.
- 28 Fedirko V, Bostick RM, Goodman M, Flanders WD, Gross MD. Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol. 2010; 172: 489–500.
- 29 Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985; 122: 51–65.
- 30 Saxena R, de Bakker PI, Singer K, et al. Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am J Hum Genet. 2006; 79: 54–61.
- 31 Thyagarajan B, Guan W, Fedirko V, et al. No association between mitochondrial DNA copy number and colorectal adenomas. Mol Carcinog. 2016; 55: 1290–1296.
- 32 Morrow JD, Roberts LJ, 2nd. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol. 1999; 300: 3–12.
- 33 Goodman M, Bostick RM, Dash C, Terry P, Flanders WD, Mandel J. A summary measure of pro- and anti-oxidant exposures and risk of incident, sporadic, colorectal adenomas. Cancer Causes Control. 2008; 19: 1051–1064.
- 34 Kassem AM, El-Guendy N, Tantawy M, Abdelhady H, El-Ghor A, Abdel Wahab AH. Mutational hotspots in the mitochondrial D-loop region of cancerous and precancerous colorectal lesions in Egyptian patients. DNA Cell Biol. 2011; 30: 899–906.
- 35 Errichiello E, Balsamo A, Cerni M, Venesio T. Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis. J Mol Med. 2015; 93: 1271–1281.
- 36 Park KS, Chan JC, Chuang LM, et al. A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians. Diabetologia. 2008; 51: 602–608.
- 37 Kang D, Miyako K, Kai Y, Irie T, Takeshige K. In vivo determination of replication origins of human mitochondrial DNA by ligation-mediated polymerase chain reaction. J Biol Chem. 1997; 272: 15275–15279.
- 38 Zhao H, Shen J, Medico L, Platek M, Ambrosone CB. Length heteroplasmies in human mitochondrial DNA control regions and breast cancer risk. Int J Mol Epidemiol Genet. 2010; 1: 184–192.
- 39 Theodoratou E, Din FV, Farrington SM, et al. Association between common mtDNA variants and all-cause or colorectal cancer mortality. Carcinogenesis. 2010; 31: 296–301.
- 40 Eide TJ. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer. 1986; 38: 173–176.